Skip to main content

Table 3 Relative frequencies of the six possible orderings among the expression values of the top-scoring triple for various studies. .

From: The ordering of expression among a few genes can provide simple cancer biomarkers and signal BRCA1 mutations

  

Colon Study

DLBCL Study

Leukemia Study

 

Ordering

Tumor

Normal

DLBCL

FL

ALL

AML

Ï€ 1

X i <X j <X k

0.125

0.045

0.362

0

0.340

0

Ï€ 2

X i <X k <X j

0.4

0

0.569

0

0

0.04

Ï€ 3

X j <X i <X k

0.075

0.864

0.052

0

0.660

0

Ï€ 4

X j <X k <X i

0

0.091

0

0.684

0

0.08

Ï€ 5

X k <X i <X j

0.4

0

0.017

0.053

0

0.76

Ï€ 6

X k <X j <X i

0

0

0

0.263

0

0.12

  

Prostate1 Study

Lung Study

GCM Study

 

Ordering

Cancer

Normal

MPM

ADCA

Tumor

Normal

Ï€ 1

X i <X j <X k

0.04

0

0

0.12

0.8

0.222

Ï€ 2

X i <X k <X j

0.1

0

0

0.827

0.113

0.5

Ï€ 3

X k <X i <X k

0.02

0.115

0.258

0.007

0.079

0.022

Ï€ 4

X j <X k <X i

0.06

0.807

0.742

0

0

0.044

Ï€ 5

X k <X i <X j

0.5

0.019

0

0.02

0.008

0.179

Ï€ 6

X k <X j <X i

0.28

0.059

0

0.027

0

0.033

  1. Each portion of the corresponds to one study with two phenotypes. For each study and each phenotype, the table shows the relative frequencies of the six possible orderings among the expression values of the top-scoring triple for the samples in the study. The gene triple (g i , g j , g k ) for each study is given in Table 4
Back to article page

BMC Bioinformatics

ISSN: 1471-2105

Contact us